Tazobactam CAS 89786-04-9 is a type of β- Lactamase inhibitors, with antibacterial activity, are suitable for sepsis, complex cystitis, and pyelonephritis caused by Staphylococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacterium, Prevotella, and Pseudomonas aeruginosa that are sensitive to this product.

Tazobactam CAS 89786-04-9 is a class of penicillinase sulfones β- Lactamase inhibitors are effective against types I-VI 3-lactamases, especially against type I enzymes. It has low toxicity, good stability, and strong enzyme inhibitory activity. Clinically used to treat infections caused by various bacteria, including aerobic and anaerobic bacteria, including lower respiratory tract infections, skin and abdominal infections, etc.

Tazobactam CAS 89786-04-9 is a type of β- Lactamase inhibitors, third-generation antimicrobial enhancers, when used in combination with piperacillin or cefoperazone, can enhance their efficacy and prolong their duration of action. When used in combination with piperacillin sodium, tazobactam sodium has a significant synergistic effect and is widely used in the treatment of severe systemic and local infections, abdominal infections, lower respiratory tract infections, soft tissue infections, sepsis, etc. It has a wider antibacterial spectrum and indications than other antibacterial complexes that have been used, demonstrating a huge advantage in overcoming drug resistance.

Tazobactam CAS 89786-04-9 can be used as a chemical raw material to synthesize Piperacillin Sodium and Tazobactam Sodium Salt.